AVTX Market Cap & Key Metrics
Avalo Therapeutics, Inc.
$6.93
-$0.52(-6.98%)
--
Overall
--
Value
--
Tech
--
Quality
Market Cap
--
Volume
4.55M
52W Range
$11.23 - $24.27
Target Price
--
AVTX market cap for Avalo Therapeutics, Inc.. This page lists Avalo Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
AVTX Key Metrics
- EPS growth, 3-year
- +82.36%
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $59.0K | $441.0K | $1.92M | $18.05M | $5.40M |
| EBITDA | -$82.10M | -$38.16M | -$27.95M | -$35.91M | -$80.50M |
| EPS | $-5.84 | $-7.94 | $-114.00 | $-1063.20 | $-14342.40 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVTX | $6.93 | -7.0% | 4.55M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Avalo Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW